000 | 01926 a2200565 4500 | ||
---|---|---|---|
005 | 20250515115810.0 | ||
264 | 0 | _c20080912 | |
008 | 200809s 0 0 eng d | ||
022 | _a1530-9932 | ||
024 | 7 |
_a10.1208/s12249-008-9062-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLimpongsa, Ekapol | |
245 | 0 | 0 |
_aPreparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system. _h[electronic resource] |
260 |
_bAAPS PharmSciTech _c2008 |
||
300 |
_a464-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium Channel Blockers _xadministration & dosage |
650 | 0 | 4 |
_aCellulose _xanalogs & derivatives |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 |
_aCitrates _xchemistry |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 |
_aDibutyl Phthalate _xchemistry |
650 | 0 | 4 | _aDiffusion |
650 | 0 | 4 | _aDiffusion Chambers, Culture |
650 | 0 | 4 |
_aDiltiazem _xadministration & dosage |
650 | 0 | 4 | _aDosage Forms |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aHypromellose Derivatives |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aMethylcellulose _xanalogs & derivatives |
650 | 0 | 4 | _aModels, Chemical |
650 | 0 | 4 |
_aMyristates _xchemistry |
650 | 0 | 4 |
_aPalmitates _xchemistry |
650 | 0 | 4 | _aPermeability |
650 | 0 | 4 |
_aPlasticizers _xchemistry |
650 | 0 | 4 |
_aPolysorbates _xchemistry |
650 | 0 | 4 |
_aSkin _xmetabolism |
650 | 0 | 4 | _aSkin Absorption |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
650 | 0 | 4 | _aTensile Strength |
650 | 0 | 4 |
_aWater _xchemistry |
700 | 1 | _aUmprayn, Kraisri | |
773 | 0 |
_tAAPS PharmSciTech _gvol. 9 _gno. 2 _gp. 464-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1208/s12249-008-9062-8 _zAvailable from publisher's website |
999 |
_c17928802 _d17928802 |